Literature DB >> 29799056

Comment on: Medication-related osteonecrosis of the jaw in osteoporotic patients: prevention and management.

Choon Lai Toh1, Andrew Dutton2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29799056      PMCID： PMC5966642          DOI： 10.11622/smedj.2018057

Source DB:  PubMed          Journal:  Singapore Med J        ISSN： 0037-5675            Impact factor:   1.858


× No keyword cloud information.
  3 in total

1.  Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons.

Authors:  Aliya A Khan; Lorena P Rios; George K B Sándor; Nazir Khan; Edmund Peters; Mohammed O Rahman; Cameron M L Clokie; Edward Dore; Sacha Dubois
Journal:  J Rheumatol       Date:  2011-04-15       Impact factor: 4.666

2.  Medication-related osteonecrosis of the jaw in osteoporotic patients: prevention and management.

Authors:  Boon Hui Chan; Ruixiang Yee; Rukshini Puvanendran; Seng Bin Ang
Journal:  Singapore Med J       Date:  2018-02       Impact factor: 1.858

3.  Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.

Authors:  Aliya A Khan; George K B Sándor; Edward Dore; Archibald D Morrison; Mazen Alsahli; Faizan Amin; Edmund Peters; David A Hanley; Sultan R Chaudry; David W Dempster; Francis H Glorieux; Alan J Neville; Reena M Talwar; Cameron M Clokie; Majd Al Mardini; Terri Paul; Sundeep Khosla; Robert G Josse; Susan Sutherland; David K Lam; Robert P Carmichael; Nick Blanas; David Kendler; Steven Petak; Louis Georges St-Marie; Jacques Brown; A Wayne Evans; Lorena Rios; Juliet E Compston
Journal:  J Rheumatol       Date:  2008-06-01       Impact factor: 4.666
  3 in total
  1 in total

1.  Comment on: Medication-related osteonecrosis of the jaw in osteoporotic patients: prevention and management.

Authors:  Wei Cheong Ngeow; Wen Lin Chai
Journal:  Singapore Med J       Date:  2019-01       Impact factor: 1.858
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.